Yanping Pan

Title: Yanping Pan: Innovator in Somatostatin Agonists

Introduction

Yanping Pan is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of somatostatin agonists. His work focuses on creating compounds that have the potential to improve therapeutic outcomes for various medical conditions.

Latest Patents

Yanping Pan holds a patent for non-peptide somatostatin agonist compounds. This invention is characterized by its potency and high selectivity toward receptor subtype 2. The compounds developed by Pan provide an improved therapeutic index in the treatment of diabetes, cancer, acromegaly, and retenosis. Notably, many of these compounds are orally active, which enhances their usability in clinical settings.

Career Highlights

Pan is currently employed at Merck & Company, Inc., a leading global healthcare company. His role at Merck allows him to leverage his expertise in drug development and innovation. With one patent to his name, he has established himself as a valuable contributor to the pharmaceutical industry.

Collaborations

Throughout his career, Yanping Pan has collaborated with esteemed colleagues, including Changyou Zhou and Alexander Pasternak. These collaborations have likely enriched his research and contributed to the advancement of his inventions.

Conclusion

In summary, Yanping Pan is an accomplished inventor whose work on somatostatin agonists has the potential to significantly impact the treatment of various diseases. His contributions to the field of pharmaceuticals exemplify the importance of innovation in healthcare.